Piperidine → HCID 21519253, 화합물

반응식

N1CCCCC1.[CH2:7]([CH2:10][NH2:11])[CH:8]=[CH2:9].[OH:12][C:13]1([CH:25]([CH3:38])[CH2:26]C2C=C(S([O-])(=O)=O)C=CC=2C)[CH2:18][CH2:17][CH2:16][CH2:15][CH:14]1[C:19]1[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=1>>[CH2:7]([CH2:10][NH:11][CH2:38][CH:25]([C:13]1([OH:12])[CH2:18][CH2:17][CH2:16][CH2:15][CH:14]1[C:19]1[CH:20]=[CH:21][CH:22]=[CH:23][CH:24]=1)[CH3:26])[CH:8]=[CH2:9]

참가 물질

반응물 3

HCID 8082Piperidine

HCID 4437323-Buten-1-amine2회

HCID 86733809HCID 86733809, 화합물2회

생성물 1

HCID 21519253HCID 21519253, 화합물

실험 절차

The procedure of Example II is followed except that piperidine is replaced by allylmethylamine. Starting with 12 g allylmethylamine and 30 g of tosylate (Compound III), 5.9 g of product is obtained.

출처 및 근거

ORD 기록: ord-e4ee9854157148c8a030a22e100bf3e7
출처 데이터셋: uspto-grants-1976_08
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US03974157

반응 노트

불러오는 중…